Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Psychotic Disorder: later-stage trial registry
3 of 6 indexed Psychotic Disorder trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Psychotic Disorder: 6 US clinical trials tracked, 3 recruiting.
Psychotic Disorder is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., running 1 of these trials.
Enrollment posture brief
Registry condition psychotic-disorder
OPEN 3 | RECR 50% | LATE 1 | EARLY 0 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Psychotic Disorder lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Psychotic Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Psychotic Disorder is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Psychotic Disorder research.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Psychotic Disorder enrolment sits around 201 participants.
Median target enrolment is 201 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Psychotic Disorder research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
University of California, San Diego
NCT07098169
Brain Stimulation to the Hippocampus in Schizophrenia
Stanford University
NCT07010614
Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital
Massachusetts General Hospital
NCT07359157
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
VA Office of Research and Development
NCT00137280
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00412373
Mobile After-Care Support App: Pilot RCT
Butler Hospital
NCT03955250
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Psychotic Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Psychotic Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Psychotic Disorder page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Psychotic Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. sponsors the most Psychotic Disorder trials on record, review their full trial history before evaluating a specific study. See Johnson & Johnson Pharmaceutical Research & Development, L.L.C.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Psychotic Disorder condition card totals 6 registered trials; most-linked intervention Mobile app attention control; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.